Cargando…

Pretreatment Serum Cystatin C Levels Predict Renal Function, but Not Tumor Characteristics, in Patients with Prostate Neoplasia

To evaluate the role of Cystatin C (Cys-C) in tumorigenesis and progression of prostate cancer (PCa), we retrospectively collected the clinical information from the records of 492 benign prostatic hyperplasia (BPH), 48 prostatic intraepithelial neoplasia (PIN), and 173 PCa patients, whose disease wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Feilong, Li, Dawei, Di, Yu, Zhang, Yongzhen, Zang, Yuanwei, Ren, Juchao, Yan, Lei, Zhou, Zunlin, Liu, Hainan, Xu, Zhonghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546082/ https://www.ncbi.nlm.nih.gov/pubmed/28812020 http://dx.doi.org/10.1155/2017/7450459

Ejemplares similares

CIP2A Promotes Proliferation, Invasion and Chemoresistance to Cisplatin in Renal Cell Carcinoma
por: Zhang, Yongzhen, et al.
Publicado: (2018)

Serum Cystatin C Level Is Not a Promising Biomarker for Predicting Clinicopathological Characteristics of Bladder Urothelial Tumors
por: Wang, Hui, et al.
Publicado: (2018)

Eukaryotic Translation Initiation Factor 3b is both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma
por: Zang, Yuanwei, et al.
Publicado: (2017)

Microvessel density and heparanase over-expression in clear cell renal cell cancer: correlations and prognostic significances
por: Ren, Juchao, et al.
Publicado: (2011)

Cytoplasmic Expression of Pontin in Renal Cell Carcinoma Correlates with Tumor Invasion, Metastasis and Patients’ Survival
por: Zhang, Xiang, et al.
Publicado: (2015)

Association between HIF1A P582S and A588T Polymorphisms and the Risk of Urinary Cancers: A Meta-Analysis
por: Li, Dawei, et al.
Publicado: (2013)

Elevated Serum Sialic Acid Levels Predict Prostate Cancer As Well As Bone Metastases
por: Zhang, Cong, et al.
Publicado: (2019)

Identification of Core Genes and Key Pathways via Integrated Analysis of Gene Expression and DNA Methylation Profiles in Bladder Cancer
por: Zhang, Yongzhen, et al.
Publicado: (2018)

Erythrocytosis caused by giant chromophobe renal cell carcinoma: a case report indicating a 9-year misdiagnosis of polycythemia vera
por: Guo, Renbo, et al.
Publicado: (2017)

Circulating Th22 cells, as well as Th17 cells, are elevated in patients with renal cell carcinoma
por: Peng, Zhiguo, et al.
Publicado: (2021)

Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9
por: Yang, Feilong, et al.
Publicado: (2018)

Prognostic Value of Pretreatment Serum Cystatin C Level in Nasopharyngeal Carcinoma Patients in the Intensity-modulated Radiotherapy Era
por: Tan, Xi-Rong, et al.
Publicado: (2021)

Reference Intervals for Serum Cystatin C and Factors Influencing Cystatin C Levels Other than Renal Function in the Elderly
por: Wei, Lu, et al.
Publicado: (2014)

Clinical Usefulness of Serum Cystatin C as a Marker of Renal Function
por: Woo, Kwang-Sook, et al.
Publicado: (2014)

Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes
por: Krolewski, Andrzej S., et al.
Publicado: (2012)

Serum Cystatin C as a Marker of Renal Function in Critically Ill Patients With Normal Serum Creatinine
por: Sagheb, Mohammad Mahdi, et al.
Publicado: (2014)

Serum Cystatin C Is a Determinant of Paraoxonase Activity in Hemodialyzed and Renal Transplanted Patients
por: Varga, Éva, et al.
Publicado: (2009)

Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma
por: Guo, Shengjie, et al.
Publicado: (2017)

Association between serum Cystatin C and renal injury in patients with chronic hepatitis B
por: Zheng, Hui, et al.
Publicado: (2020)

Serum cystatin C is an early renal dysfunction biomarker in patients with hepatitis C virus
por: Assem, Nagwa Mohamed, et al.
Publicado: (2022)

Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer
por: Gashenko, Elena A., et al.
Publicado: (2013)

Serum Cystatin C Reflects the Progress of Albuminuria
por: Yoo, Jeong Seon, et al.
Publicado: (2011)

Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients
por: Villa, Patricia, et al.
Publicado: (2005)

Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy
por: Royakkers, Annick A. N. M., et al.
Publicado: (2010)

Serum cystatin C as a marker of renal function in detection of early acute kidney injury
por: Murty, M. S. N., et al.
Publicado: (2013)

Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis
por: Omar, Mahmoud, et al.
Publicado: (2015)

Serum Cystatin C Predicts Stroke Clinical Outcomes at 1 Year Independent of Renal Function
por: Ding, Yarong, et al.
Publicado: (2021)

Comparing the Value of Cystatin C and Serum Creatinine for Evaluating the Renal Function and Predicting the Prognosis of COVID-19 Patients
por: Chen, Sichao, et al.
Publicado: (2021)

Serum Creatinine and Serum Cystatin C are Both Relevant Renal Markers to Estimate Vancomycin Clearance in Critically Ill Neonates
por: Leroux, Stéphanie, et al.
Publicado: (2021)

Serum Cystatin C is a Potential Endogenous Marker for the Estimation of Renal Function in Male Gout Patients with Renal Impairment
por: Choe, Jung-Yoon, et al.
Publicado: (2010)

Lower serum cystatin C level predicts poor functional outcome in patients with hypertensive intracerebral hemorrhage independent of renal function
por: Zhou, Yongfang, et al.
Publicado: (2022)

Serum Cystatin C and Tubular Urinary Enzymes as Biomarkers of Renal Dysfunction in Type 2 Diabetes Mellitus
por: Assal, Heba S., et al.
Publicado: (2013)

Serum cystatin C is an independent biomarker associated with the renal resistive index in patients with chronic kidney disease
por: Ogawa-Akiyama, Ayu, et al.
Publicado: (2018)

Serum Cystatin, Chemokine, and Gastrin-Releasing Peptide Precursors and Their Clinical Value in Patients with Chronic Renal Failure
por: Liu, Xiaoli, et al.
Publicado: (2022)

Clinical significance of serum cystatin C in early evaluation of renal impairment caused by chemotherapy in elderly patients
por: Li, Wen-Hui, et al.
Publicado: (2020)

Prognostic value of preoperative serum cystatin-C level for non-metastatic renal cell carcinoma—correspondence
por: Tang, Yaxiong, et al.
Publicado: (2023)

Serum Cystatin C Concentrations in Patients with Graves’ Ophthalmopathy
por: Can, Nagehan, et al.
Publicado: (2020)

Downregulation of HDGF inhibits the tumorigenesis of bladder cancer cells by inactivating the PI3K-AKT signaling pathway
por: Zhang, Cong, et al.
Publicado: (2019)

Cystatin-C as a Marker for Renal Impairment in Preeclampsia
por: Niraula, Apeksha, et al.
Publicado: (2017)

Serum cystatin C can be used as a marker of renal function even in patients with intestinal urinary diversion
por: Matsuki, Masahiro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_b6a3nd6fek4cofbgidd60qdtj6